Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) EPS (Weighted Average and Diluted): 2013-2025

Historic EPS (Weighted Average and Diluted) for MediWound (MDWD) over the last 7 years, with Sep 2025 value amounting to -$0.59.

  • MediWound's EPS (Weighted Average and Diluted) fell 5243.22% to -$0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.25, marking a year-over-year increase of 99.97%. This contributed to the annual value of -$3.03 for FY2024, which is 304.00% down from last year.
  • Per MediWound's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.59 for Q3 2025, which was down 938.81% from $0.07 recorded in Q2 2025.
  • MediWound's EPS (Weighted Average and Diluted)'s 5-year high stood at $9,217 during Q3 2023, with a 5-year trough of -$8,944 in Q4 2023.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $24.74, with a median of $0.01 in 2024.
  • Examining YoY changes over the last 5 years, MediWound's EPS (Weighted Average and Diluted) showed a top increase of 3,896,664.42% in 2022 and a maximum decrease of 188,670.30% in 2022.
  • MediWound's EPS (Weighted Average and Diluted) (Quarterly) stood at $2.41 in 2021, then slumped by 188,670.30% to -$4,550 in 2022, then tumbled by 96.57% to -$8,944 in 2023, then spiked by 99.99% to -$0.83 in 2024, then plummeted by 5,243.22% to -$0.59 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.59 in Q3 2025, compared to $0.07 in Q2 2025 and -$0.90 in Q1 2025.